Hypotensive central infarction of the spinal cord.

Focal cervical poliopathy causing juvenile muscular atrophy of distal upper extremity: a pathological study. J Neurol Neurosurg Psychiatry (1987) 1.62

Smoking is Associated with Increased Blood Loss and Transfusion Use After Lumbar Spinal Surgery. Clin Orthop Relat Res (2015) 0.87

Neurologic manifestations associated with dissecting aneurysm of the aorta. J Am Med Assoc (1950) 2.79

Dissecting aortic aneurysm with infarction of the spinal cord. Brain (1956) 1.83

Vulnerability of human spinal cord in transient cardiac arrest. Neurology (1971) 1.34

Paralysis following surgical correction of coarctation of the aorta; case report with autopsy findings. Surgery (1953) 1.14

Differential vulnerability of spinal cord structures to anoxia. J Neurophysiol (1955) 1.08

Diffuse "anoxic" myelopathy. Neurology (1977) 1.05

[Spinal-cord lesions following temporary circulatory arrest]. Z Neurol (1973) 0.96

Primary LAMP-2 deficiency causes X-linked vacuolar cardiomyopathy and myopathy (Danon disease). Nature (2000) 5.71

Decline in skeletal muscle mitochondrial respiratory chain function: possible factor in ageing. Lancet (1989) 3.27

Musculoskeletal assessment of general medical in-patients--joints still crying out for attention. Rheumatology (Oxford) (2003) 2.39

Helper virus induced T cell lymphoma in nonhuman primates after retroviral mediated gene transfer. J Exp Med (1992) 2.12

Effect of global system for mobile communication (gsm)-like radiofrequency fields on vascular permeability in mouse brain. Pathology (2001) 1.75

SUMO-1 marks the nuclear inclusions in familial neuronal intranuclear inclusion disease. Exp Neurol (2003) 1.66

Normal variants of human mitochondrial DNA and translation products: the building of a reference data base. Hum Genet (1991) 1.62

Development of a high-titer retrovirus producer cell line capable of gene transfer into rhesus monkey hematopoietic stem cells. Proc Natl Acad Sci U S A (1990) 1.59

Diagnostic screening of mitochondrial DNA mutations in Australian adults 1990-2001. Intern Med J (2004) 1.53

Clinicopathological features of genetically confirmed Danon disease. Neurology (2002) 1.51

Hydroxyurea-induced HbF production in anemic primates: augmentation by erythropoietin, hematopoietic growth factors, and sodium butyrate. Exp Hematol (1992) 1.50

Chronic fatigue and myalgia syndrome: mitochondrial and glycolytic studies in skeletal muscle. J Neurol Neurosurg Psychiatry (1987) 1.48

Breastmilk oversupply despite retained placental fragment. J Hum Lact (1992) 1.40

Autoimmune myasthenia gravis: place of thymectomy and preferred technique. Intern Med J (2002) 1.38

Neuropathology of immunohistochemically identified brainstem neurons in Parkinson's disease. Ann Neurol (1990) 1.37

Characterization of two classes of ribonucleoprotein complexes possibly involved in RNA editing from Leishmania tarentolae mitochondria. EMBO J (1994) 1.36

In situ and in vitro study of colocalization and segregation of alpha-synuclein, ubiquitin, and lipids in Lewy bodies. Exp Neurol (2000) 1.35

Creutzfeldt-Jakob disease in a recipient of human pituitary-derived gonadotrophin. Aust N Z J Med (1990) 1.30

The solubility of alpha-synuclein in multiple system atrophy differs from that of dementia with Lewy bodies and Parkinson's disease. J Neurochem (2001) 1.29

Loss of brainstem serotonin- and substance P-containing neurons in Parkinson's disease. Brain Res (1990) 1.28

Traumatic brain injury. Vet Pathol (2002) 1.28

Reduced collagen VI causes Bethlem myopathy: a heterozygous COL6A1 nonsense mutation results in mRNA decay and functional haploinsufficiency. Hum Mol Genet (1998) 1.28

A tRNA(Lys) mutation in the mtDNA is the causal genetic lesion underlying myoclonic epilepsy and ragged-red fiber (MERRF) syndrome. Am J Hum Genet (1991) 1.27

Brain weights in alcoholics. J Neurol Neurosurg Psychiatry (1982) 1.26

Patient self-efficacy and health locus of control: relationships with health status and arthritis-related expenditure. Rheumatology (Oxford) (2005) 1.25

Respiratory chain encephalomyopathies: a diagnostic classification. Eur Neurol (1996) 1.22

Carbamazepine therapy complicated by nodal bradycardia and water intoxication. Aust N Z J Med (1979) 1.19

Multiple-system atrophy: a new alpha-synuclein disease? Lancet (1998) 1.18

Comparison of laparoscopic adjustable gastric banding (LAGB) with other bariatric procedures; a systematic review of the randomised controlled trials. Surgeon (2012) 1.18

Partial cytochrome oxidase (aa3) deficiency in chronic progressive external ophthalmoplegia. Histochemical and biochemical studies. J Neurol Sci (1985) 1.15

Alpha-synuclein immunoisolation of glial inclusions from multiple system atrophy brain tissue reveals multiprotein components. J Neurochem (1999) 1.12

Presymptomatic motor neuron loss and reactive astrocytosis in the SOD1 mouse model of amyotrophic lateral sclerosis. Muscle Nerve (2001) 1.11

Single fibre EMG studies in chronic fatigue syndrome: a reappraisal. J Neurol Neurosurg Psychiatry (1994) 1.10

Genome-wide association analysis of coffee drinking suggests association with CYP1A1/CYP1A2 and NRCAM. Mol Psychiatry (2011) 1.08

Myostatin, insulin-like growth factor-1, and leukemia inhibitory factor mRNAs are upregulated in chronic human disuse muscle atrophy. Muscle Nerve (2001) 1.07

Quadriceps muscle wasting persists 5 months after total hip arthroplasty for osteoarthritis of the hip: a pilot study. Intern Med J (2001) 1.06

A new disease-related mutation for mitochondrial encephalopathy lactic acidosis and strokelike episodes (MELAS) syndrome affects the ND4 subunit of the respiratory complex I. Am J Hum Genet (1992) 1.03

Neuroradiological features of six kindreds with MELAS tRNA(Leu) A2343G point mutation: implications for pathogenesis. J Neurol Neurosurg Psychiatry (1998) 1.03

The neuropathology of melioidosis: two cases and a review of the literature. Clin Neuropathol (2004) 1.02

Isometric strength and thickness relationships in human quadriceps muscle. Neuromuscul Disord (1995) 1.00

Pigmentary retinopathy associated with the mitochondrial DNA 3243 point mutation. Neurology (1997) 1.00

Cochlear origin of hearing loss in MELAS syndrome. Ann Neurol (1998) 0.99

Upregulation of amyloid precursor protein messenger RNA in response to traumatic brain injury: an ovine head impact model. Exp Neurol (1999) 0.98

Paranodal pathology in Tangier disease with remitting-relapsing multifocal neuropathy. J Clin Neurosci (2006) 0.95

The pathologic effects of intrathecal betamethasone. Spine (Phila Pa 1976) (1997) 0.95

Mitochondrial respiratory chain activity in the human brain as a function of age. Mech Ageing Dev (1999) 0.95

Mitochondrial DNA polymorphism in disease: a possible contributor to respiratory dysfunction. Hum Mol Genet (1994) 0.94

Neuronal damage produced in rat brains by Clostridium perfringens type D epsilon toxin. J Comp Pathol (1999) 0.94

Neoplastic cerebral aneurysm from metastatic gestational choriocarcinoma. Case report. J Neurosurg (1985) 0.94

Mitochondrial respiratory chain activity in idiopathic dilated cardiomyopathy. J Card Fail (2000) 0.93

Detection of MELAS A3243G point mutation in muscle, blood and hair follicles. J Neurol Sci (1998) 0.93

Vasculitis of peripheral nerve and skeletal muscle: clinicopathological correlation and immunopathic mechanisms. J Neurol Sci (1990) 0.92

Mitochondrial myopathies: defects in mitochondrial metabolism in human skeletal muscle. Biochem Soc Trans (1983) 0.92

Primary (granulomatous) angiitis of the central nervous system with multiple aneurysms of spinal arteries. Case report. J Neurosurg (1993) 0.91

Historical and current concepts in mitochondrial myopathies. Aust N Z J Med (1983) 0.91

Mitochondrial myopathies: disorders of the respiratory chain and oxidative phosphorylation. J Inherit Metab Dis (1984) 0.90

Giant cell arteritis. A five-year review of biopsy-proven cases in a teaching hospital. Med J Aust (1980) 0.90

Clostridium perfringens prototoxin-induced alteration of endothelial barrier antigen (EBA) immunoreactivity at the blood-brain barrier (BBB). Exp Neurol (2001) 0.90

In vivo and in vitro correction of the mdx dystrophin gene nonsense mutation by short-fragment homologous replacement. Hum Gene Ther (2001) 0.90

Mitochondrial studies in Kearns-Sayre syndrome: normal respiratory chain function with absence of a mitochondrial translation product. Neurology (1987) 0.90

Intradural cyst with compression of the cauda equina in ankylosing spondylitis. Surg Neurol (1985) 0.90

Age-related loss of dorsal vagal neurons in Parkinson's disease. Neurology (1992) 0.90

Malignant melanoma metastatic to a meningioma. Pathology (1999) 0.89

Ubiquitin-positive degenerating neurites in the brainstem in Parkinson's disease. Brain (1995) 0.89

Developmental genetics of deleted mtDNA in mitochondrial oculomyopathy. J Neurol Sci (1997) 0.89

Efficient in vivo marking of primary CD4+ T lymphocytes in nonhuman primates using a gibbon ape leukemia virus-derived retroviral vector. Blood (1997) 0.88

Tissue segregation of a heteroplasmic mtDNA mutation in MERRF (myoclonic epilepsy with ragged red fibers) encephalomyopathy. Hum Genet (1992) 0.88

Clinical features of mitochondrial myopathy. Aust N Z J Med (1983) 0.87

alpha-Synuclein fibrils constitute the central core of oligodendroglial inclusion filaments in multiple system atrophy. Exp Neurol (2003) 0.87

Chronic relapsing myalgia (? Post viral): clinical, histological, and biochemical studies. Aust N Z J Med (1985) 0.87

Ataxia-without-telangiectasia. Progressive multisystem degeneration with IgE deficiency and chromosomal instability. J Neurol Sci (1985) 0.87

Polymyositis presenting with respiratory failure. J Neurol Sci (1984) 0.87

Excitotoxic model of post-traumatic syringomyelia in the rat. Spine (Phila Pa 1976) (2001) 0.87

Oxygen electrode studies with human skeletal muscle mitochondria in vitro. A re-appraisal. J Neurol Sci (1985) 0.86

Substance P-containing neurons in the mesopontine tegmentum are severely affected in Parkinson's disease. Brain (1991) 0.86

Nurses' job satisfaction and organizational climate in a dynamic work environment. Appl Nurs Res (2000) 0.86

Antimitochondrial autoantibodies of primary biliary cirrhosis as a novel probe in the study of 2-oxo acid dehydrogenases in patients with mitochondrial myopathies. J Neurol Sci (1990) 0.86

Experimentally induced defects of mitochondrial metabolism in rat skeletal muscle. Biological effects of the mitochondrial uncoupling agent 2,4-dinitrophenol. Biochem J (1985) 0.86

Fulminant leucocytoclastic brainstem vasculitis in a patient with otherwise indolent systemic lupus erythematosus. Lupus (2009) 0.85

Alpha B-crystallin is a major component of glial cytoplasmic inclusions in multiple system atrophy. Neurotox Res (2005) 0.85

Quantitative measure of muscle strength and size in chronic alcoholism: an early indication of tissue damage. Drug Alcohol Rev (1996) 0.85

Mitochondrial DNA deletion in encephalomyopathy. Lancet (1988) 0.84

Mitochondrial myoneuropathy with respiratory failure and myoclonic epilepsy. A case report with biochemical studies. J Neurol Sci (1985) 0.84

Brain injury patterns in fatally injured pedestrians. J Trauma (1994) 0.84

Targeted gene correction in the mdx mouse using short DNA fragments: towards application with bone marrow-derived cells for autologous remodeling of dystrophic muscle. Gene Ther (2002) 0.84

Irregular distribution of cytochrome c oxidase protein subunits in aging and Alzheimer's disease. Ann Neurol (1999) 0.84

A novel mtDNA deletion in an infant with Pearson syndrome. J Inherit Metab Dis (1994) 0.84

SUMO-1 marks subdomains within glial cytoplasmic inclusions of multiple system atrophy. Neurosci Lett (2005) 0.83

Mitochondrial encephalomyopathies: a correlation between neuropathological findings and defects in mitochondrial DNA. J Neurol Sci (1991) 0.83

Cerebral malakoplakia. J Clin Pathol (1981) 0.83

Central core disease. Study of a family with five affected generations. J Neurol Sci (1982) 0.83

Haemangiopericytoma presenting as recurrent intracranial haemorrhage. J Clin Neurosci (1997) 0.83

Sporadic Leber hereditary optic neuropathy in Australia and New Zealand. Aust N Z J Ophthalmol (1996) 0.83

Mitochondrial encephalomyopathy: variable clinical expression within a single kindred. J Neurol Neurosurg Psychiatry (1993) 0.83

Mitochondrial DNA sequence analysis in congenital myotonic dystrophy. Ann Neurol (1991) 0.83

Anti-Yo positive paraneoplastic cerebellar degeneration: a report of three cases and review of the literature. J Clin Neurosci (1995) 0.83

Patterns of immunocytochemical staining for ferritin and transferrin in the human spinal cord following traumatic injury. J Clin Neurosci (2002) 0.83